Antimicrobial susceptibility testing was performed with the broth dilution method in accordance with the Clinical and Laboratory Standards Institute (CLSI) document M07 guidelines (19 ). The following antimicrobial agents were used for antimicrobial susceptibility testing: ceftazidime, aztreonam, piperacillin, tazobactam, ciprofloxacin, sulfamethoxazole, and trimethoprim (Tokyo Chemical Industry Co., Ltd., Tokyo, Japan); meropenem, cefotaxime, and gentamicin (Wako Pure Chemical Industries, Ltd., Tokyo, Japan); moxalactam and amikacin (Sigma-Aldrich Inc., St. Louis, MO, USA); imipenem (Combi-Blocks, Inc., San Diego, CA, USA); and cefepime (Toronto Research Chemicals, Toronto, Ontario, Canada). MIC values ranged from 0.12 to 256 μg/mL (trimethoprim/sulfamethoxazole from 0.015/0.3 to 32/608 μg/mL). E. coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were used as the quality control strains for antibiotic susceptibility testing. The results were interpreted in accordance with CLSI guidelines (20 ).
Tazobactam
Manufactured by Tokyo Chemical Industry
Sourced in Japan
Tazobactam is a β-lactamase inhibitor used in combination with various β-lactam antibiotics. It helps to prevent the breakdown of antibiotics by certain enzymes, thereby enhancing the effectiveness of the antibiotic.
Automatically generated - may contain errors
Lab products found in correlation
Ciprofloxacin, by Tokyo Chemical Industry (2 mentions)
Gentamicin, by Fujifilm (2 mentions)
Aztreonam, by Tokyo Chemical Industry (2 mentions)
Ceftazidime, by Tokyo Chemical Industry (2 mentions)
Cefotaxime, by Fujifilm (2 mentions)
Meropenem, by Fujifilm (2 mentions)
Piperacillin, by Tokyo Chemical Industry (2 mentions)
Sulfamethoxazole, by Tokyo Chemical Industry (2 mentions)
Trimethoprim, by Tokyo Chemical Industry (2 mentions)
Moxalactam and amikacin, by Merck Group (2 mentions)
Cefepime, by LGC (2 mentions)
Imipenem, by Combi-Blocks (2 mentions)
2 protocols using tazobactam
1
Antimicrobial Susceptibility Testing Protocol
2
Antimicrobial Susceptibility Testing Protocol
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Antimicrobial susceptibility testing was performed with the broth dilution method in accordance with the Clinical and Laboratory Standards Institute (CLSI) document M07 guidelines (19 ). The following antimicrobial agents were used for antimicrobial susceptibility testing: ceftazidime, aztreonam, piperacillin, tazobactam, ciprofloxacin, sulfamethoxazole, and trimethoprim (Tokyo Chemical Industry Co., Ltd., Tokyo, Japan); meropenem, cefotaxime, and gentamicin (Wako Pure Chemical Industries, Ltd., Tokyo, Japan); moxalactam and amikacin (Sigma-Aldrich Inc., St. Louis, MO, USA); imipenem (Combi-Blocks, Inc., San Diego, CA, USA); and cefepime (Toronto Research Chemicals, Toronto, Ontario, Canada). MIC values ranged from 0.12 to 256 μg/mL (trimethoprim/sulfamethoxazole from 0.015/0.3 to 32/608 μg/mL). E. coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were used as the quality control strains for antibiotic susceptibility testing. The results were interpreted in accordance with CLSI guidelines (20 ).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!